VRCA
Verrica Pharmaceuticals Inc
4.20$
+1.0%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | |||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 32.4 | 25.9 | 28.7 | – | – | – | – | 12.7 | 32.4 | 30.9 | 56.1 | 66.0 | 30.8 | 24.4 | 7.6 | 6.2 | 5.8 | 3.4 | 1.3 | 2.5 | 3.0 | 4.3 | |
| – | – | – | – | – | – | 4.3 | 4.2 | 2.3 | 3.2 | 3.8 | 5.1 | 6.1 | 4.8 | 5.7 | 4.9 | 8.7 | 6.3 | 6.0 | 8.4 | 7.8 | 8.8 | 3.2 | 2.9 | 2.9 | 4.3 | 4.8 | 4.2 | 17.1 | 181.9 | – | – | – | – | – | – | 3.6 | 7.0 | 30.2 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 32.2 | 27.3 | 30.4 | – | – | – | – | 9.0 | 25.5 | 24.6 | 43.1 | 60.9 | 30.2 | 25.3 | 10.0 | 6.0 | 7.5 | 5.0 | 1.8 | 1.7 | 2.5 | 3.9 | |
| – | – | – | – | – | – | -2.0% | -3.2% | -9.2% | -8.7% | -8.5% | -7.4% | -7.1% | -10.9% | -12.2% | -17.3% | -11.0% | -8.8% | -7.5% | -7.6% | -11.2% | -11.5% | -67.4% | -17.7% | -16.5% | -5.4% | -4.7% | -16.3% | -11.5% | -19.8% | -19.4% | -84.9% | -129.3% | -128.0% | -94.1% | -71.3% | -19.9% | -12.5% | -10.3% | |
| Margins | |||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 58.4% | 59.0% | 59.8% | -7.3% | -308.2% | -146.7% | -61.0% | -146.3% | 63.8% | 71.8% | 86.6% | 91.4% | 90.4% | 89.5% | 85.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -252.0% | -269.5% | -287.3% | – | – | – | – | -235.8% | -242.8% | -272.7% | -1,524.1% | -1,283.3% | -866.9% | -581.4% | -843.1% | -871.3% | -772.4% | -263.4% | -53.2% | -33.6% | -36.4% | -92.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -281.7% | -301.5% | -321.0% | – | – | – | – | -271.1% | -261.7% | -272.2% | -1,507.9% | -1,307.5% | -905.8% | -625.1% | -922.8% | -1,012.1% | -919.2% | -330.5% | -84.4% | -50.3% | -48.0% | -102.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -284.7% | -193.8% | -218.1% | – | – | – | – | -209.8% | -176.1% | -146.4% | -912.1% | -759.9% | -609.1% | -474.0% | -647.4% | -805.6% | -747.8% | -322.1% | -94.4% | -49.5% | -38.0% | -44.0% | |
| Returns | |||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | -20.8% | -10.5% | -16.6% | -24.8% | -33.5% | -37.5% | -39.3% | -43.4% | -54.0% | -68.0% | -95.3% | -129.4% | -54.7% | -69.4% | -94.3% | -107.6% | -167.7% | -251.1% | -62.8% | -61.2% | -34.9% | -42.3% | -114.2% | -339.0% | -5,353.9% | – | – | – | – | – | – | -72.3% | -111.0% | -724.0% | |
| – | – | – | – | -49.1% | -19.6% | -10.1% | -16.2% | -24.1% | -32.3% | -35.4% | -37.0% | -41.2% | -32.3% | -37.8% | -46.7% | -57.6% | -31.3% | -36.5% | -43.4% | -43.8% | -59.5% | -64.6% | -57.2% | -54.8% | -32.9% | -37.7% | -49.7% | -82.1% | -121.8% | -167.1% | -258.1% | -141.5% | -156.5% | -124.3% | -63.6% | -37.9% | -46.0% | -86.6% | |
| Balance Sheet & Debt | |||||||||||||||||||||||||||||||||||||||
| -0.5 | 0.6 | – | – | -8.6 | -27 | -103 | -38 | – | -24 | -20 | -10 | -9.1 | -20 | -14 | 18 | 60 | -3.2 | 17 | 21 | 26 | 32 | 37 | -32 | -34 | -60 | -55 | -42 | -26 | -5.1 | 12 | 22 | -1.7 | 12 | 23 | 14 | -29 | -20 | -10 | |
| 23.0% | – | – | – | -77.5% | 94.4% | 97.0% | 97.5% | 97.3% | 96.3% | 94.6% | 94.2% | 95.0% | 59.9% | 55.6% | 49.0% | 44.5% | 57.2% | 52.7% | 46.0% | 40.7% | 35.5% | 25.7% | 91.1% | 89.5% | 94.5% | 89.1% | 43.5% | 24.2% | 2.3% | -25.6% | -103.4% | -18.2% | -44.0% | -44.7% | -41.7% | 52.5% | 41.4% | 12.0% | |
| 0.3 | 0.3 | – | – | – | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.6 | 0.7 | 0.9 | 2.1 | 0.7 | 0.8 | 1.0 | 1.3 | 1.7 | 2.6 | 0.0 | 0.0 | 0.0 | 0.0 | 1.0 | 2.2 | 29.1 | – | – | – | – | – | – | 0.0 | 0.0 | 0.2 | |
| Per Share | |||||||||||||||||||||||||||||||||||||||
| – | – | – | -1.92 | -2.24 | -2.57 | -4.74 | -6.44 | -8.91 | -11.17 | -11.58 | -11.31 | -11.32 | -12.24 | -13.20 | -14.95 | -17.03 | -13.21 | -13.15 | -14.00 | -12.75 | -15.49 | -14.90 | -6.29 | -5.96 | -5.25 | -5.10 | -10.49 | -14.47 | -17.37 | -18.69 | -18.16 | -11.37 | -6.96 | -5.12 | -2.74 | -1.68 | -0.84 | -1.46 | |
| – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.69 | 4.36 | 4.36 | 0.00 | -4.20 | -4.13 | -0.68 | 2.20 | 2.01 | 1.87 | 0.70 | 1.11 | 1.92 | 2.99 | 1.97 | 1.12 | 0.76 | 1.55 | 3.25 | 3.34 | 1.74 | 1.42 | |
| – | 0.05 | – | – | -3.53 | 12.39 | 45.36 | 38.78 | 35.99 | 33.29 | 30.89 | 28.78 | 26.09 | 22.68 | 19.41 | 15.68 | 13.16 | 24.14 | 18.96 | 14.85 | 11.85 | 9.24 | 5.94 | 10.02 | 9.74 | 15.07 | 12.07 | 9.18 | 4.27 | 0.32 | -2.86 | -7.28 | -1.46 | -1.96 | -1.84 | -1.80 | 2.32 | 0.75 | 0.20 | |
| – | – | – | – | -2.30 | -2.79 | -3.96 | -5.21 | -7.50 | -9.41 | -9.92 | -11.02 | -11.27 | -11.93 | -13.39 | -13.31 | -12.64 | -13.35 | -8.45 | -9.51 | -10.34 | -9.34 | -12.81 | -5.12 | -4.61 | -3.53 | -2.74 | -6.34 | -8.41 | -11.68 | -14.18 | -12.74 | -9.05 | -5.66 | -4.99 | -3.07 | -1.65 | -0.66 | -0.63 | |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.